| Product Name | NebuSelect™ Recombinant Canine Oncostatin M/OSM, His-tag |
|---|---|
| Catalog Number | NBL-241451 |
| Alias/Synonyms | Oncostatin M/OSM |
| Appearance | see COA |
| Molecule Weight | Ser27-Arg207 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | A0A8I3Q5M1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241451-100ug | 100ug | Inquire | Inquire | |
| NBL-241451-1mg | 1mg | Inquire | Inquire | |
| NBL-241451-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Canine Oncostatin M/OSM, His-tag
Catalog#:
NBL-241451
Description:
NebuSelect™ Recombinant Canine Oncostatin M/OSM, His-tag(Cat#NBL-241451) is expressed in HEK293 with His tag at the C-Terminus.It contains Ser27-Arg207.
Species:
Canine
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 21.65 kDa. Due to glycosylation, the protein migrates to 27-35 kDa based on Bis-Tris PAGE result.
Target Name:
Oncostatin M/OSM
Target Information:
OSM is a pleiotropic cytokine that initiates its biological activities by binding to specific cell surface receptors. Inhibits the proliferation of a number of tumor cell lines. Stimulates proliferation of AIDS-KS cells. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells. Uses both type I OSM receptor (heterodimers composed of LIFR and IL6ST) and type II OSM receptor (heterodimers composed of OSMR and IL6ST). Involved in the maturation of fetal hepatocytes, thereby promoting liver development and regeneration.
Amino Acid Sequence:
Ser27-Arg207
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.